Pascual-Figal, Domingo AFuster, José J2025-12-182025-12-182025-11-09JAMA Cardiol. 2025 Nov 9.https://hdl.handle.net/20.500.12105/27090Dr Fuster reported grants from “la Caixa” Foundation under project code LCF/PR/HR22/52420011 and grants from the Instituto de Salud Carlos III (ISCIII), co-funded by the European Union’s NextGenerationEU under the umbrella of the partnership Fostering a European Research Area for Health (ERA4Health) (grant 101095426 of the European Union’s Horizon Europe Research and Innovation Programme). Dr Pascual-Figal reported being principal investigator for “Role of Somatic Mutations and Clonal Hematopoiesis in the Progression of Heart Failure,” funded by a grant from ISCIII (PI20/00677), and principal investigator for “Precision Biomarkers for Diagnosis and Management of Myocardial Inflammatory Diseases (Pre-MYO Project)” (NCT06898762), funded by a grant from ISCIII (PMP22/00105) and the European Union through the NextGenerationEU Recovery, Transformation, and Resilience Plan. No other disclosures were reported.engAMhttp://creativecommons.org/licenses/by-nc-nd/4.0/Clonal Hematopoiesis-An Opportunity to Confront the Heart Failure Epidemic.Attribution-NonCommercial-NoDerivatives 4.0 International41206887JAMA CARDIOLOGYopen access